drugset
Drugs / GLYCAR T cells
last change Jan 2023 re-read 3 minutes ago

GLYCAR T cells

Developed for
hepatocellular carcinoma
Investigated by
Baylor College of Medicine · Cancer Prevention Research Institute of Texas · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Trials 1

today NCT02905188 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02905188 Mar 2019 → Nov 2021 hepatocellular carcinoma Baylor College of Medicine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GLYCAR T cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT02905188 ↗
Action Deplete “make them recognize cancer cells and kill them” NCT02905188 ↗
Route Other “the cells will then be thawed and injected into the patient over 1 to 10 minutes” NCT02905188 ↗